Extracellular exopolymer, process for its preparation and pharma

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 11, 536123, C12P 1904, C07H 100

Patent

active

051148480

ABSTRACT:
An extracellular exopolymer endowed with immunomodulating properties is prepared by culturing the Bifidobacterium infantis longum strain deposited at the Institut Pasteur under No. I-885 in a suitable medium under anaerobic conditions. After the microorganisms are discarded from the culture medium, the exopolymer thus produced is isolated, concentrated and then precipitated by adding an organic solvent; finally the product resulting from the precipitation is lyophilized.
The exopolymer thus obtained possesses an activity on cellular as well as on humoral immunity, and could thus be used as an immunomodulating agent in any potential therapeutic application.

REFERENCES:
patent: 4435389 (1984-03-01), Mutai et al.
patent: 4645667 (1987-02-01), Hashimoto et al.
patent: 4797589 (1989-01-01), Nakaya et al.
Shimamura et al., Agric. Biol. Chem., vol. 54 (11), p. 2869, 1990.
"Structural Studies of Cell Wall Polysaccharides from Bifidobacterium breve YIT 4010 and Related Bifidobacterium Species", Journal of Biochemistry, vol. 102, No. 6, 1987, by Y. Habu et al., pp. 1423-1432.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Extracellular exopolymer, process for its preparation and pharma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Extracellular exopolymer, process for its preparation and pharma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extracellular exopolymer, process for its preparation and pharma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2417095

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.